157 related articles for article (PubMed ID: 23696788)
1. Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma.
Agarwal S; Al-Keilani MS; Alqudah MA; Sibenaller ZA; Ryken TC; Assem M
PLoS One; 2013; 8(5):e62852. PubMed ID: 23696788
[TBL] [Abstract][Full Text] [Related]
2. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells.
Novellino L; De Filippo A; Deho P; Perrone F; Pilotti S; Parmiani G; Castelli C
Cell Signal; 2008 May; 20(5):872-83. PubMed ID: 18276111
[TBL] [Abstract][Full Text] [Related]
3. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
[TBL] [Abstract][Full Text] [Related]
4. Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.
Sun PH; Chen G; Mason M; Jiang WG; Ye L
Int J Oncol; 2017 Apr; 50(4):1127-1135. PubMed ID: 28259897
[TBL] [Abstract][Full Text] [Related]
5. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133.
Matsushita M; Mori Y; Uchiumi K; Ogata T; Nakamura M; Yoda H; Soda H; Takiguchi N; Nabeya Y; Shimozato O; Ozaki T
FEBS Open Bio; 2019 May; 9(5):935-946. PubMed ID: 30947381
[TBL] [Abstract][Full Text] [Related]
6. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
Shimozato O; Waraya M; Nakashima K; Souda H; Takiguchi N; Yamamoto H; Takenobu H; Uehara H; Ikeda E; Matsushita S; Kubo N; Nakagawara A; Ozaki T; Kamijo T
Oncogene; 2015 Apr; 34(15):1949-60. PubMed ID: 24882578
[TBL] [Abstract][Full Text] [Related]
7. Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes.
Xu Y; Xue S; Zhou J; Voorhees JJ; Fisher GJ
Mol Biol Cell; 2015 Mar; 26(6):1199-206. PubMed ID: 25609089
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.
Sun PH; Ye L; Mason MD; Jiang WG
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1129-39. PubMed ID: 23552869
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
[TBL] [Abstract][Full Text] [Related]
10. IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in Glioma cells in vitro and in vivo.
Wang JB; Dong DF; Wang MD; Gao K
Asian Pac J Cancer Prev; 2014; 15(1):427-32. PubMed ID: 24528069
[TBL] [Abstract][Full Text] [Related]
11. Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway.
Sun PH; Ye L; Mason MD; Jiang WG
Int J Oncol; 2013 Nov; 43(5):1560-8. PubMed ID: 24002526
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PTPRK Promotes Cell Proliferation and Metastasis of NSCLC by Enhancing STAT3 Activation.
Xu X; Li D; Liu J; Ma Z; Huang H; Min L; Dai L; Dong S
Anal Cell Pathol (Amst); 2019; 2019():4265040. PubMed ID: 30838170
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine phosphatase-kappa regulates CD4+ T cell development through ERK1/2-mediated signaling.
Erdenebayar N; Maekawa Y; Nishida J; Kitamura A; Yasutomo K
Biochem Biophys Res Commun; 2009 Dec; 390(3):489-93. PubMed ID: 19800317
[TBL] [Abstract][Full Text] [Related]
14. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
[No Abstract] [Full Text] [Related]
15. The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer.
Chang LS; Kim M; Glinka A; Reinhard C; Niehrs C
Elife; 2020 Jan; 9():. PubMed ID: 31934854
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
[TBL] [Abstract][Full Text] [Related]
17. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion.
Fearnley GW; Young KA; Edgar JR; Antrobus R; Hay IM; Liang WC; Martinez-Martin N; Lin W; Deane JE; Sharpe HJ
Elife; 2019 Mar; 8():. PubMed ID: 30924770
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
[TBL] [Abstract][Full Text] [Related]
19. β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways.
Gao Y; Yang F; Su Z; He Z; Xiao J; Xu Y; Zha X; Xu F; Wang L
Biochem Biophys Res Commun; 2018 Oct; 505(2):569-577. PubMed ID: 30274773
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
Tentori L; Portarena I; Torino F; Scerrati M; Navarra P; Graziani G
Glia; 2002 Oct; 40(1):44-54. PubMed ID: 12237842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
